Professor, Medicine, University of Pittsburgh School of Medicine
Gastroenterology
Dr. Randall E. Brand, MD
|
|
Give Review
Randall Brand is an expert in the field of Gastroenterology. He went to University of Michigan Medical School. He over the years received 4 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Fellow (AGAF)" and "Fellow (FACG)". Dr. Randall E. Brand is also published. He has 71 publications published. The lastest publication: "Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women: Analysis of a Large Multicenter Cohort.' Randall Brand accepts Medicare.
Publications
- Endoscopic ultrasound-guided FNA and ProCore biopsy in sampling pancreatic and intra-Abdominal masses.
- Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
- Early Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens.
- A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts.
- Peripancreatic fat necrosis worsens acute Pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections.
- Distribution of Cholecystokinin-B Receptor Genotype Between Patients With Pancreatic Cancer and Controls and Its Impact on Survival.
- A MicroRNA-Based Test Improves Endoscopic Ultrasound-Guided Cytologic Diagnosis of Pancreatic Cancer.
- Chronic Pancreatitis Pain Pattern and Severity are Independent of Abdominal Imaging Findings.
- Decade in review-pancreatic Diseases: Advances in understanding and care of pancreatic Diseases.
- Mechanisms of CFTR Functional Variants That Impair Regulated Bicarbonate Permeation and Increase Risk for Pancreatitis but Not for Cystic Fibrosis.
- Spectrum of use and effectiveness of endoscopic and surgical therapies for chronic Pancreatitis in the United States.
- Phenethyl Isothiocyanate Inhibits Proliferation and Induces Apoptosis in Pancreatic Cancer Cells In Vitro and in a MIAPaca2 Xenograft Animal Model.
- Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
- Specific Glycoforms of MUC5AC and Endorepellin Accurately Distinguish Mucinous from Nonmucinous Pancreatic Cysts.
- Lynch syndrome-associated Colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach.
- Variation in the γ-glutamyltransferase 1 gene and risk of chronic Pancreatitis.
- Signet Ring Cell Colorectal Carcinoma: A Distinct Subset of Mucin-poor Microsatellite-stable Signet Ring Cell Carcinoma Associated With Dismal Prognosis.
- Investigation of depth-resolved nanoscale structural changes in regulated cell proliferation and chromatin decondensation.
- Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer.
- Modulation of glycan detection on specific glycoproteins by lectin multimerization.
- Physical and Mental Quality of Life in Chronic Pancreatitis: A Case-Control Study From the North American Pancreatitis Study 2 Cohort.
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic Pancreatitis.
- Alcohol and tobacco lower the age of presentation in sporadic pancreatic Cancer in a dose-dependent manner: a multicenter study.
- Investigation of nuclear nano-morphology marker as a biomarker for Cancer risk assessment using a mouse model.
- Correction of stain variations in nuclear refractive index of clinical histology specimens.
- Targeting ALDHbright human carcinoma initiating cells with ALDH1A1- specific CD8+ T cells.
- Quantification of nanoscale nuclear refractive index changes during the cell cycle.
- Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic Diseases.
- Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic Cancer.
- New developments in pancreatic Cancer.
- Detection of the potential pancreatic Cancer marker MUC4 in serum using surface-enhanced Raman scattering.
- Using optical markers of nondysplastic rectal epithelial cells to identify patients with Ulcerative colitis-associated neoplasia.
- Serum biomarker panels for the detection of pancreatic Cancer.
- Depth-selective fiber-optic probe for characterization of superficial tissue at a constant physical depth.
- Enhanced discrimination of malignant from Benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.
- Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic Pancreatitis in patients without cystic fibrosis.
- Transcriptional profiling of peripheral blood mononuclear cells in pancreatic Cancer patients identifies novel genes with potential diagnostic utility.
- Nanoscale nuclear architecture for Cancer diagnosis beyond pathology via spatial-domain low-coherence quantitative phase microscopy.
- An insight into statistical refractive index properties of cell internal structure via low-coherence statistical amplitude microscopy.
- Spatial-domain low-coherence quantitative phase microscopy for Cancer diagnosis.
- Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute Pancreatitis.
- Pancreatic Cancer patients who smoke and drink are diagnosed at younger ages.
- Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy.
- The prevalence and nature of glycan alterations on specific proteins in pancreatic Cancer patients revealed using antibody-lectin sandwich arrays.
- Association between rectal optical signatures and colonic neoplasia: potential applications for screening.
- Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to Cancer diagnosis.
- Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia risk.
- Spectral slope from the endoscopically-normal mucosa predicts concurrent colonic neoplasia: a pilot ex-vivo clinical study.
- Screening for pancreatic Cancer: current evidence and future directions.
- Genetic predisposition to pancreatic Cancer: a brief review.
- Optical markers in duodenal mucosa predict the presence of pancreatic Cancer.
- Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma.
- Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.
- MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications.
- Genotype/phenotype of familial pancreatic Cancer.
- Associations between the age at diagnosis and location of Colorectal cancer and the use of alcohol and tobacco: implications for screening.
- Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats.
- Recent advances on the molecular mechanisms involved in pancreatic Cancer progression and therapies.
- A prospective study of Gastric emptying and its relationship to the development of nausea, vomiting, and anorexia after autologous stem cell transplantation.
- BRCA1 and pancreatic Cancer: pedigree findings and their causal relationships.
- Identification of high-risk pancreatic Cancer-prone families.
- Reproducibility of a multitarget stool-based DNA assay for Colorectal cancer detection.
- Endoluminal delivery of radiofrequency energy to the gastroEsophageal junction in uncomplicated GERD: efficacy and potential mechanism of action.
- Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mol...
- The specificity of amylin for the diagnosis of pancreatic adenocarcinoma.
- First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch Syndrome.
- Prediagnostic serum biomarkers as early detection tools for pancreatic Cancer in a large prospective cohort study.
- Detection, evaluation and treatment of diabetes mellitus in chronic Pancreatitis: Recommendations from PancreasFest 2012.
- Nuclear Nano-architecture Markers of Gastric Cardia and Upper Squamous Esophagus Detect Esophageal Cancer "Field Effect".
- Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women: Analysis of a Large Multicenter Cohort.
Schools
University of Mi Med Sch
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Fecal Impaction Removal
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
- Fellow (FACG)
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1255361184 | |
| NPPES Provider LastName | BRAND | |
| NPPES Provider FirstName | RANDALL | |
| NPPES Provider ZIPCode | 152321300 | |
| NPPES Provider State | PA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 185.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1255361184 |
| Last Name Of The Provider | BRAND |
| First Name Of The Provider | RANDALL |
| View All |
Similar Doctors
|
|
Dr. Klaus Bielefeldt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael F. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James B. McGee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzanne K. Morrissey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven R. Abo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dhiraj Yadav, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parth S. Bharill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Refaat Hegazi, MD |
|
|
Juan C. Lopez-Talavera |